Logo
Homepage
Explore Our Models
My Cart
Contact
Subscribe
Models
Genetically Engineered Animals
Knockout Mice
Knockout Rats
Knockin Mice
Knockin Rats
Transgenic Mice
Transgenic Rats
Model Generation Techniques
Turboknockout<sup>®</sup> Gene Targeting
ES Cell Gene Targeting
Targeted Gene Editing
Regular Transgenic
PiggyBac Transgenesis
BAC Transgenic
Research Models
HUGO-GT™ Humanized Mice
Cre Mouse Lines
Humanized Target Gene Models
Metabolic Disease Models
Ophthalmic Disease Models
Neurological Disease Models
Autoimmune Disease Models
Immunodeficient Mouse Models
Humanized Immune System Mouse Models
Oncology & Immuno-oncology Models
Covid-19 Mouse Models
MouseAtlas Model Library
Knockout Cell Line Product Catalog
Tumor Cell Line Product Catalog
AAV Standard Product Catalog
Animal Supporting Services
Breeding Services
Cryopreservation & Recovery
Phenotyping Services
BAC Modification
Custom Cell Line Models
Induced Pluripotent Stem Cells (iPSCs)
Knockout Cell Lines
Knockin Cell Lines
Point Mutation Cell Lines
Overexpression Cell Lines
Virus Packaging
Adeno-associated Virus (AAV) Packaging
Lentivirus Packaging
Adenovirus Packaging
CRO Services
By Therapeutic Area
Oncology
Ophthalmology
Neuroscience
Metabolic & Cardiovascular Diseases
Autoimmune & Inflammatory
By Drug Type
AI-Powered AAV Discovery
Gene Therapy
Oligonucleotide Therapy
Antibody Therapy
Cell Immunotherapy
Resources
Promotion
Events & Webinars
Newsroom
Blogs & Insights
Resource Vault
Reference Databases
Peer-Reviewed Citations
Rare Disease Data Center
AbSeek
Cell iGeneEditor™ System
OriCell
Quality
Facility Overview
Animal Health & Welfare
Health Reports
About Us
Corporate Overview
Our Partners
Careers
Contact Us
Login
Request a Product Quote
Select products from our catalogs and submit your request. Our team will get back to you with detailed information.
Full Name
Email
Phone Number
Organization
Job Role
Country
Catalog Type
Product Name
Additional Comments
Cyagen values your privacy. We’d like to keep you informed about our latest offerings and insights. Your preferences:
You may unsubscribe from these communications at any time. See our Privacy Policy for details on opting out and data protection.
By clicking the button below, you consent to allow Cyagen to store and process the personal information submitted in this form to provide you the content requested.
C57BL/6JCya-Fam50aem1flox/Cya
Common Name:
Fam50a-flox
Product ID:
S-CKO-00671
Background:
C57BL/6JCya
Product Type
Age
Genotype
Sex
Quantity
Price:
Contact for Pricing
Basic Information
Strain Name
Fam50a-flox
Strain ID
CKOCMP-108160-Fam50a-B6J-VA
Gene Name
Fam50a
Product ID
S-CKO-00671
Gene Alias
D0HXS9928E; XAP-5
Background
C57BL/6JCya
NCBI ID
108160
Modification
Conditional knockout
Chromosome
X
Phenotype
MGI:1351626
Document
Click here to download >>
Application
--
More
Rare Disease Data Center >>
Note
Note: When using this mouse strain in a publication, please cite “C57BL/6JCya-Fam50aem1flox/Cya mice (Catalog S-CKO-00671) were purchased from Cyagen.”
Strain Description
Ensembl Number
ENSMUST00000114160
NCBI RefSeq
NM_138607
Target Region
Exon 2~4
Size of Effective Region
~1.4 kb
Detailed Document
Click here to download >>
Overview of Gene Research
Fam50a, a gene encoding a nuclear protein, is involved in mRNA processing, especially as a component of the spliceosome complex C, and may act as a DNA-binding protein or transcription factor [2,4,5]. It is associated with various biological processes and diseases.

In cancer, integrative pan-cancer analysis shows that Fam50a mRNA level is upregulated in 20 out of 33 types of common cancer tissues. In 8 of these 20 types, upregulation is accompanied by promoter hypomethylation. Elevated expression in 10 types of cancer tissues is linked to poor prognosis. Fam50a knockdown causes DNA damage, induces interferon beta and interleukin-6 expression, and represses cancer cell proliferation, invasion, and migration [1]. In colorectal cancer, knockdown of Fam50a decreases cell proliferation, increases the number of cells in the S phase, and reduces CyclinA2 and CDK2 levels, suggesting its role in regulating tumor progression via the CyclinA2/CDK2 pathway [3]. In hepatocellular carcinoma, it has cancer-promoting effects, can regulate the tumor immune microenvironment, and serves as a diagnostic marker, immunomodulator, and therapeutic target [4]. In Kaposi's sarcoma-associated herpesvirus-induced cellular transformation, FAM50A is crucial, and its knockout inhibits viral-driven proliferation, cellular transformation, and tumorigenesis by altering SHP2 splicing and reducing STAT3 Y705 phosphorylation [5].

For neurodevelopmental disorders, mutations in Fam50a cause Armfield XLID syndrome, a spliceosomopathy. The fam50a knockout zebrafish model exhibits abnormal neurogenesis and craniofacial patterning, with dysregulation of the transcriptome, augmented spliceosome mRNAs, and depletion of neurodevelopment-related transcripts. A unique DNA methylation episignature associated with this disorder has also been detected [2,6].

In summary, Fam50a plays significant roles in cancer development and neurodevelopmental disorders, and gene knockout models, such as in zebrafish for neurodevelopmental studies and in cancer cell lines for cancer-related research, have been instrumental in revealing these functions.

References:
1. Hu, Mei-Zhen, Dai, Zhi-Zheng, Ji, Hong-Yu, Zhu, Shu-Juan, Wang, Ke-Jian. 2023. Upregulation of FAM50A promotes cancer development. In Medical oncology (Northwood, London, England), 40, 217. doi:10.1007/s12032-023-02072-z. https://pubmed.ncbi.nlm.nih.gov/37393403/
2. Lee, Yu-Ri, Khan, Kamal, Armfield-Uhas, Kim, Davis, Erica E, Schwartz, Charles E. 2020. Mutations in FAM50A suggest that Armfield XLID syndrome is a spliceosomopathy. In Nature communications, 11, 3698. doi:10.1038/s41467-020-17452-6. https://pubmed.ncbi.nlm.nih.gov/32703943/
3. Li, Longhai, Ji, Zhaoshuai, Li, Guangyun, Gu, Hao, Sun, Yan. 2025. FAM50A as a novel prognostic marker modulates the proliferation of colorectal cancer cells via CylinA2/CDK2 pathway. In PloS one, 20, e0318776. doi:10.1371/journal.pone.0318776. https://pubmed.ncbi.nlm.nih.gov/39999107/
4. Xie, Xudong, Li, Li, Tao, Shuai, Huang, Chenlu, Chen, Liang. 2023. Proto-Oncogene FAM50A Can Regulate the Immune Microenvironment and Development of Hepatocellular Carcinoma In Vitro and In Vivo. In International journal of molecular sciences, 24, . doi:10.3390/ijms24043217. https://pubmed.ncbi.nlm.nih.gov/36834630/
5. Sun, Shenyu, Paniagua, Karla, Ding, Ling, Flores, Mario A, Gao, Shou-Jiang. 2025. KSHV Reprograms Host RNA Splicing via FAM50A to Activate STAT3 and Drive Oncogenic Cellular Transformation. In bioRxiv : the preprint server for biology, , . doi:10.1101/2025.03.17.643747. https://pubmed.ncbi.nlm.nih.gov/40166334/
6. Haghshenas, Sadegheh, Levy, Michael A, Kerkhof, Jennifer, Sadikovic, Bekim, Schwartz, Charles. 2021. Detection of a DNA Methylation Signature for the Intellectual Developmental Disorder, X-Linked, Syndromic, Armfield Type. In International journal of molecular sciences, 22, . doi:10.3390/ijms22031111. https://pubmed.ncbi.nlm.nih.gov/33498634/
Quality Control Standard
Sperm Test

Pre-cryopreservation: Measurement of sperm concentration, determination of sperm viability.

Post-cryopreservation: A vial of cryopreserved sperms is selected for in-vitro fertilization from each batch.

Environmental Standards:SPF
Available Region:Global
Source:Cyagen
Model Library
Model Library
Resources
Resources
Animal Quality
Animal Quality
Get Support
Get Support
Address:
2255 Martin Avenue, Suite E Santa Clara, CA 95050-2709, US
Tel:
800-921-8930 (8-6pm PST)
+1408-963-0306 (lnt’l)
Fax:
408-969-0338
Email:
animal-service@cyagen.com
service@cyagen.us
CRO Services
OncologyOphthalmologyNeuroscienceMetabolic & CardiovascularAutoimmune & InflammatoryGene TherapyAntibody Therapy
About Us
Corporate OverviewOur PartnersCareersContact Us
Social Media
Disclaimer: Pricing and availability of our products and services vary by region. Listed prices are applicable to the specific countries. Please contact us for more information.
Copyright © 2025 Cyagen. All rights reserved.
Privacy Policy
Site Map
Stay Updated with the Latest from Cyagen
Get the latest news on our research models, CRO services, scientific resources, and special offers—tailored to your research needs and delivered straight to your inbox.
Full Name
Email
Organization
Country
Areas of Interest